Inventor · disambiguated record
Janak Khimchand Padia
Also filed as: PADIA JANAK · PADIA JANAK K · PADIA JANAK KHIMCHAND
19 granted patents·6 pending applications·577 citations·filing 1991–2024
95Inventor score
Files withWARNER LAMBERT CO9SUPERNUS PHARMACEUTICALS INC6CONVERGENE LLC4CHOLODY WIESLAW M2DOGWOOD PHARMACEUTICALS INC1
Top patents by PatentIndex Score
25 records- 0197US11634415B2Derivatives of substituted morpholines and uses thereofSUPERNUS PHARMACEUTICALS INC·Filed 2022·Granted Apr 25, 2023·5 cites·29 claims
- 0297US5869665AQuinazolinone derivatives as cholecystokinin (CCK) ligandsWARNER LAMBERT CO·Filed 1997·Granted Feb 9, 1999·115 cites·9 claims
- 0397US5756502AQuinazolinone derivatives as cholyecystokinin (CCK) ligandsWARNER LAMBERT CO·Filed 1995·Granted May 26, 1998·122 cites·6 claims
- 0495US12215097B2Derivatives of substituted morpholines and uses thereofSUPERNUS PHARMACEUTICALS INC·Filed 2024·Granted Feb 4, 2025·1 cites·27 claims
- 0593US8129519B2Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereofCHOLODY WIESLAW M·Filed 2008·Granted Mar 6, 2012·97 cites·6 claims
- 0692US11919889B2Derivatives of substituted morpholines and uses thereofSUPERNUS PHARMACEUTICALS INC·Filed 2022·Granted Mar 5, 2024·1 cites·15 claims
- 0792US9695179B2Methods and compositions for inhibition of bromodomain-containing proteinsCONVERGENE LLC·Filed 2014·Granted Jul 4, 2017·22 cites·36 claims
- 0886US2025122180A1Derivatives of substituted morpholines and uses thereofSUPERNUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0984US6011052APyrazolone derivatives as MCP-1 antagonistsWARNER LAMBERT CO·Filed 1997·Granted Jan 4, 2000·40 cites·18 claims
- 1083US5972980AMethod for treating and preventing inflammation and atherosclerosisWARNER LAMBERT CO·Filed 1996·Granted Oct 26, 1999·71 cites·2 claims
- 1181US5958950ABenzimidazole compounds useful for the treatment of inflammatory disease, atherosclerosis, restenosis or inhibiting lipoxygenaseWARNER LAMBERT CO·Filed 1996·Granted Sep 28, 1999·64 cites·22 claims
- 1279US10266536B2Methods and compositions for inhibition of bromodomain-containing proteinsCONVERGENE LLC·Filed 2017·Granted Apr 23, 2019·2 cites·29 claims
- 1376US2024343699A1Derivatives of substituted morpholines and uses thereofSUPERNUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1476US2024336581A1Derivatives of substituted morpholines and uses thereofSUPERNUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1570US5593967ACholecystokinin antagonists, their preparation and therapeutic useWARNER LAMBERT CO·Filed 1993·Granted Jan 14, 1997·22 cites·8 claims
- 1667US10717739B2Methods and compositions for inhibition of bromodomain-containing proteinsCONVERGENE LLC·Filed 2019·Granted Jul 21, 2020·0 cites·19 claims
- 1760US2023002389A1Adenine analogs, prodrugs, derivatives, compositions and uses thereofPADIA JANAK KHIMCHAND·Filed 2022·Application pending·0 cites
- 1857US6875884B1Urea derivatives as inhibitors for CCR-3 receptorKIRIN BREWERY·Filed 2000·Granted Apr 5, 2005·3 cites·25 claims
- 1954US9120754B2Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereofCHOLODY WIESLAW M·Filed 2012·Granted Sep 1, 2015·0 cites·19 claims
- 2051US9446021B2Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereofDOGWOOD PHARMACEUTICALS INC·Filed 2015·Granted Sep 20, 2016·0 cites·15 claims
- 2151US5846942ACholecystokinin antagonists, their preparation and therapeutic useWARNER LAMBERT CO·Filed 1996·Granted Dec 8, 1998·5 cites·6 claims
- 2248US6897213B1Heterocycles as cholecystokinin (CCK) ligandsWARNER LAMBERT CO·Filed 1997·Granted May 24, 2005·3 cites·12 claims
- 2347US5208224APhosphorus containing compounds as antihypercholesterolemic and antiatherosclerotic agentsWARNER LAMBERT CO·Filed 1991·Granted May 4, 1993·4 cites·6 claims
- 2436US2005032794A1Diamine derivatives of quinone and uses thereofFiled 2004·Application pending·0 cites
- 2535US2019092761A1Methods and Compositions for Inhibition of Bromodomain and Extratermial ProteinsCONVERGENE LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Janak Khimchand Padia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →